Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
News for CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) is closely tied to the operating and capital markets activities of CareCloud, Inc., a healthcare technology and AI-focused company. Investors following CCLDO typically monitor company announcements about preferred stock dividends, redemption terms, financial performance, acquisitions, and AI product launches, since these developments provide context for the preferred security.
CareCloud regularly issues press releases detailing its preferred stock dividend policies and payments. For the Series B Preferred Stock, the company has announced monthly cash dividends, described the cumulative nature of those dividends, and outlined record and payment dates. It has also communicated plans to address accumulated dividend arrears on the Series B Preferred Stock through double monthly dividend payments that combine regular dividends with catch-up payments until past due amounts are fully satisfied.
Beyond dividend-specific updates, the news flow includes information about CareCloud’s broader business performance and strategy. The company has reported quarterly financial results, discussed revenue guidance, and highlighted periods of positive GAAP net income and adjusted EBITDA. It has also described acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, which expand its presence in hospital and integrated health system markets and support its AI-driven revenue cycle and benchmarking capabilities.
CareCloud’s news also covers AI product introductions and enhancements, including the launch of stratusAI Desk Agent, an AI phone receptionist for patient access, and the integration of stratusAI Voice Audit for conversational intelligence and call analytics. Additional announcements describe the deployment of the Wellsoft emergency department information system in urgent care settings and the company’s AI Center of Excellence, which supports innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement.
Investors and observers who track CCLDO can use this news stream to see how CareCloud’s dividend practices, redemption options, AI initiatives, acquisitions, and financial performance evolve over time. These updates provide insight into both the preferred stock’s income characteristics and the underlying healthcare technology platform that supports the issuer.
CareCloud (Nasdaq: CCLD) announced a new partnership with Arkansas Otolaryngology Center to deploy AI-enabled practice management and revenue cycle management (RCM) solutions across the multi-location ENT practice.
The collaboration will deliver AI-powered claims management, automated denial prevention, coding education, real-time dashboards, and AI-driven financial analytics aimed at accelerating revenue capture and improving clean claim rates, with the company emphasizing reductions in days in accounts receivable and enhanced operational transparency.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.
CareCloud (Nasdaq: CCLD) is showcasing its enhanced MAP App at the HFMA Revenue Cycle Conference in Arlington, March 19, 2026, demonstrating updates made since acquiring the platform from HFMA.
The company will host a networking happy hour on March 19 and a live webinar on April 7, 2026 at 1:00 PM ET to review product updates, roadmap, and use cases.
CareCloud (Nasdaq: CCLD) will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on March 17, 2026, featuring a company fireside chat streamed live to registered attendees.
CareCloud recently reported full-year 2025 results: its first full year of positive EPS since IPO, exceeded its upsized revenue forecast range, and increased free cash flow by more than 500% over three years. A replay will be available at the company investor relations site.
CareCloud (Nasdaq: CCLD) will ring the Nasdaq Closing Bell on May 19, 2026 and host its 2026 Analyst Day at the Nasdaq MarketSite in New York City. The event will showcase new AI-powered products and a management business update on strategic priorities.
The announcement highlights CareCloud reporting its first full year of positive EPS since its IPO 12 years ago and a roughly 18% rise in its common stock over two trading days after release of full-year 2025 results.
CareCloud (Nasdaq: CCLD) reported full‑year 2025 revenue of $120.5M (+8.7% YoY), GAAP net income of $10.8M (+37.5% YoY) and its first full‑year positive GAAP EPS since its 2014 IPO of $0.10. The company closed acquisitions including Medsphere, entered inpatient software, launched AI products, generated $28.6M cash from operations and repaid its credit line.
Management issued 2026 guidance: $128–$132M revenue, $29–$31M adjusted EBITDA and GAAP EPS of $0.20–$0.23.
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
A conference call for investors will follow at 8:30 a.m. ET with a live webcast, audio options, downloadable slides, and a replay available at ir.carecloud.com/events.
CareCloud (Nasdaq: CCLD) announced a new contract with Memorial Hospital in Marysville, Ohio to deploy the HealthLine clinical supply chain platform. HealthLine, acquired via CareCloud's August 2025 purchase of Medsphere, aims to reduce supply waste, improve charge capture, and free clinicians from manual inventory tasks.
The platform delivers point-of-use scanning, automated charge capture, mobility, specialized modules for high-cost areas, and a modern architecture; CareCloud plans to add AI capabilities over coming quarters to boost efficiency and insights.
CareCloud (NASDAQ: CCLD) announced that its Wellsoft Emergency Department Information System was ranked #1 EHR for Emergency Medicine by Black Book 2026. Black Book's ranking is based on independent surveys of 33,178 physician practices and ambulatory facilities collected over nine months and highlights Wellsoft's ED-ready workflow speed, throughput visibility, and operational reliability.
Wellsoft joined CareCloud through the acquisition of Medsphere and has prior recognition from KLAS more than ten times. CareCloud said Affinity Urgent Care selected Wellsoft for its Houston-Galveston clinics, positioning the company to expand emergency-grade EDIS into the ~11,000 urgent care facility U.S. market and to integrate with its revenue cycle, analytics, and AI solutions.